COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89bio, Inc. | Common | 282559103 | 1,612,827 | 105,898 | SH | | SOLE | | 1,612,827 | 0 | 0 |
Abbott Laboratories | Common | 002824100 | 63,171,557 | 623,855 | SH | | SOLE | | 63,171,557 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 81,533,533 | 511,599 | SH | | SOLE | | 81,533,533 | 0 | 0 |
Acadia Healthcare Company, Inc. | Common | 00404A109 | 13,473,686 | 186,487 | SH | | SOLE | | 13,473,686 | 0 | 0 |
Adaptive Biotechnologies Corp. | Common | 00650F109 | 3,728,741 | 422,281 | SH | | SOLE | | 3,728,741 | 0 | 0 |
Addus HomeCare Corp. | Common | 006739106 | 4,524,489 | 42,380 | SH | | SOLE | | 4,524,489 | 0 | 0 |
Adicet Bio, Inc. | Common | 007002108 | 232,295 | 40,329 | SH | | SOLE | | 232,295 | 0 | 0 |
Affimed N.V. | Common | N01045108 | 436,950 | 586,038 | SH | | SOLE | | 436,950 | 0 | 0 |
Agilent Technologies, Inc. | Common | 00846U101 | 5,975,043 | 43,191 | SH | | SOLE | | 5,975,043 | 0 | 0 |
Align Technology, Inc. | Common | 016255101 | 2,313,920 | 6,925 | SH | | SOLE | | 2,313,920 | 0 | 0 |
Alkermes plc | Shares | G01767105 | 8,727,990 | 309,613 | SH | | SOLE | | 8,727,990 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 28,688,628 | 143,214 | SH | | SOLE | | 28,688,628 | 0 | 0 |
Altimmune, Inc. | Common | 02155H200 | 316,500 | 75,000 | SH | | SOLE | | 316,500 | 0 | 0 |
ALX Oncology Holdings Inc. | Common | 00166B105 | 299,274 | 66,211 | SH | | SOLE | | 299,274 | 0 | 0 |
Amedisys, Inc. | Common | 023436108 | 5,071,199 | 68,949 | SH | | SOLE | | 5,071,199 | 0 | 0 |
Amerisourcebergen Corp. | Common | 03073E105 | 3,268,966 | 20,417 | SH | | SOLE | | 3,268,966 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 134,398,253 | 555,939 | SH | | SOLE | | 134,398,253 | 0 | 0 |
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 8,912,779 | 135,124 | SH | | SOLE | | 8,912,779 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y506 | 64,597 | 32,461 | SH | | SOLE | | 64,597 | 0 | 0 |
Arcus Biosciences, Inc. | Common | 03969F109 | 598,983 | 32,839 | SH | | SOLE | | 598,983 | 0 | 0 |
Arcutis Biotherapeutics, Inc. | Common | 03969K108 | 1,637,614 | 148,874 | SH | | SOLE | | 1,637,614 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 2,583,764 | 539,408 | SH | | SOLE | | 2,583,764 | 0 | 0 |
argenx SE | Sponsored ADR | 04016X101 | 32,902,540 | 88,310 | SH | | SOLE | | 32,902,540 | 0 | 0 |
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 2,550,719 | 100,422 | SH | | SOLE | | 2,550,719 | 0 | 0 |
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 13,272,871 | 123,791 | SH | | SOLE | | 13,272,871 | 0 | 0 |
Assertio Holdings, Inc. | Common | 04546C205 | 2,615,363 | 410,575 | SH | | SOLE | | 2,615,363 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 68,900,808 | 992,664 | SH | | SOLE | | 68,900,808 | 0 | 0 |
Avantor, Inc. | Common | 05352A100 | 9,713,576 | 459,488 | SH | | SOLE | | 9,713,576 | 0 | 0 |
Baxter International, Inc. | Common | 071813109 | 2,730,175 | 67,312 | SH | | SOLE | | 2,730,175 | 0 | 0 |
Beam Therapeutics Inc. | Common | 07373V105 | 484,317 | 15,817 | SH | | SOLE | | 484,317 | 0 | 0 |
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 4,515,785 | 20,952 | SH | | SOLE | | 4,515,785 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481404 | 1,980 | 6,000 | SH | | SOLE | | 1,980 | 0 | 0 |
Bicycle Therapeutics PLC | Sponsored ADS | 088786108 | 1,886,139 | 88,676 | SH | | SOLE | | 1,886,139 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | Common | 09058V103 | 4,207,764 | 504,528 | SH | | SOLE | | 4,207,764 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 66,984,656 | 240,926 | SH | | SOLE | | 66,984,656 | 0 | 0 |
Biohaven Ltd. | Common | G1110E107 | 479,288 | 35,087 | SH | | SOLE | | 479,288 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 29,180,654 | 300,089 | SH | | SOLE | | 29,180,654 | 0 | 0 |
BioNTech SE | Sponsored ADS | 09075V102 | 12,937,591 | 103,858 | SH | | SOLE | | 12,937,591 | 0 | 0 |
Black Diamond Therapeutics, Inc. | Common | 09203E105 | 249,461 | 131,990 | SH | | SOLE | | 249,461 | 0 | 0 |
Blueprint Medicines Corp. | Common | 09627Y109 | 3,046,273 | 67,710 | SH | | SOLE | | 3,046,273 | 0 | 0 |
Boston Scientific Corp. | Common | 101137107 | 28,316,480 | 565,990 | SH | | SOLE | | 28,316,480 | 0 | 0 |
Bridgebio Pharma, Inc. | Common | 10806X102 | 2,502,270 | 150,921 | SH | | SOLE | | 2,502,270 | 0 | 0 |
Bristol-Myers Squibb Company | Common | 110122108 | 46,007,701 | 663,796 | SH | | SOLE | | 46,007,701 | 0 | 0 |
Cardiovascular Systems, Inc. | Common | 141619106 | 3,472,700 | 174,859 | SH | | SOLE | | 3,472,700 | 0 | 0 |
Caribou Biosciences, Inc. | Common | 142038108 | 3,011,551 | 567,147 | SH | | SOLE | | 3,011,551 | 0 | 0 |
Catalent, Inc. | Common | 148806102 | 3,246,468 | 49,406 | SH | | SOLE | | 3,246,468 | 0 | 0 |
Cerevel Therapeutics Holdings, Inc. | Common | 15678U128 | 4,304,420 | 176,483 | SH | | SOLE | | 4,304,420 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 23,831,511 | 118,083 | SH | | SOLE | | 23,831,511 | 0 | 0 |
Chinook Therapeutics, Inc. | Common | 16961L106 | 1,933,025 | 83,500 | SH | | SOLE | | 1,933,025 | 0 | 0 |
The Cigna Group | Common | 125523100 | 46,667,699 | 182,631 | SH | | SOLE | | 46,667,699 | 0 | 0 |
Codexis Inc | Common | 192005106 | 286,178 | 69,125 | SH | | SOLE | | 286,178 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 432,842 | 88,335 | SH | | SOLE | | 432,842 | 0 | 0 |
Community Healthcare Trust Inc. | Common | 20369C106 | 545,340 | 14,900 | SH | | SOLE | | 545,340 | 0 | 0 |
Corbus Pharmaceuticals Holdings, Inc. | Common | 21833P301 | 37,390 | 5,143 | SH | | SOLE | | 37,390 | 0 | 0 |
Crinetics Pharmaceuticals, Inc. | Common | 22663K107 | 1,261,176 | 78,529 | SH | | SOLE | | 1,261,176 | 0 | 0 |
CRISPR Therapeutics AG | Namen AKT | H17182108 | 2,491,268 | 55,080 | SH | | SOLE | | 2,491,268 | 0 | 0 |
CVS Health Corp. | Common | 126650100 | 6,956,977 | 93,621 | SH | | SOLE | | 6,956,977 | 0 | 0 |
Cytokinetics, Inc. | Common | 23282W605 | 7,707,490 | 219,025 | SH | | SOLE | | 7,707,490 | 0 | 0 |
Danaher Corp. | Common | 235851102 | 26,638,108 | 105,690 | SH | | SOLE | | 26,638,108 | 0 | 0 |
Denali Therapeutics, Inc. | Common | 24823R105 | 7,484,060 | 324,829 | SH | | SOLE | | 7,484,060 | 0 | 0 |
Dexcom, Inc. | Common | 252131107 | 26,575,826 | 228,747 | SH | | SOLE | | 26,575,826 | 0 | 0 |
Diversified Healthcare Trust | Common | 25525P107 | 482,922 | 357,720 | SH | | SOLE | | 482,922 | 0 | 0 |
Edgewise Therapeutics, Inc. | Common | 28036F105 | 1,300,817 | 195,025 | SH | | SOLE | | 1,300,817 | 0 | 0 |
Edwards Lifesciences Corp. | Common | 28176E108 | 14,158,909 | 171,146 | SH | | SOLE | | 14,158,909 | 0 | 0 |
Elevance Health, Inc. | Common | 036752103 | 52,450,527 | 114,070 | SH | | SOLE | | 52,450,527 | 0 | 0 |
Eli Lilly and Company | Common | 532457108 | 99,219,876 | 288,917 | SH | | SOLE | | 99,219,876 | 0 | 0 |
Exelixis, Inc. | Common | 30161Q104 | 14,104,063 | 726,639 | SH | | SOLE | | 14,104,063 | 0 | 0 |
Fulcrum Therapeutics, Inc. | Common | 359616109 | 166,830 | 58,537 | SH | | SOLE | | 166,830 | 0 | 0 |
Fusion Pharmaceuticals Inc. | Common | 36118A100 | 163,595 | 43,394 | SH | | SOLE | | 163,595 | 0 | 0 |
G1 Therapeutics, Inc. | Common | 3621LQ109 | 1,135,969 | 423,869 | SH | | SOLE | | 1,135,969 | 0 | 0 |
Galera Therapeutics, Inc. | Common | 36338D108 | 2,299,837 | 898,374 | SH | | SOLE | | 2,299,837 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 129,423,575 | 1,559,884 | SH | | SOLE | | 129,423,575 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 1,593,312 | 174,897 | SH | | SOLE | | 1,593,312 | 0 | 0 |
GSK plc | Sponsored ADR | 37733W204 | 1,489,094 | 41,852 | SH | | SOLE | | 1,489,094 | 0 | 0 |
Guardant Health, Inc. | Common | 40131M109 | 11,067,993 | 472,184 | SH | | SOLE | | 11,067,993 | 0 | 0 |
Harpoon Therapeutics, Inc. | Common | 41358P106 | 193,425 | 259,910 | SH | | SOLE | | 193,425 | 0 | 0 |
HCA Healthcare, Inc. | Common | 40412C101 | 23,389,207 | 88,703 | SH | | SOLE | | 23,389,207 | 0 | 0 |
Healthcare Realty Trust Inc. | Common | 42226K105 | 3,376,680 | 174,686 | SH | | SOLE | | 3,376,680 | 0 | 0 |
Healthpeak Properties, Inc. | Common | 42250P103 | 3,304,112 | 150,392 | SH | | SOLE | | 3,304,112 | 0 | 0 |
Humana Inc. | Common | 444859102 | 17,862,015 | 36,794 | SH | | SOLE | | 17,862,015 | 0 | 0 |
I-Mab | Sponsored ADS | 44975P103 | 562,527 | 162,580 | SH | | SOLE | | 562,527 | 0 | 0 |
Icon plc | Shares | G4705A100 | 1,993,649 | 9,334 | SH | | SOLE | | 1,993,649 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 29,302,188 | 58,595 | SH | | SOLE | | 29,302,188 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 80,945,771 | 348,079 | SH | | SOLE | | 80,945,771 | 0 | 0 |
Immunovant, Inc. | Common | 45258J102 | 1,789,854 | 115,400 | SH | | SOLE | | 1,789,854 | 0 | 0 |
Intellia Therapeutics, Inc. | Common | 45826J105 | 5,749,606 | 154,269 | SH | | SOLE | | 5,749,606 | 0 | 0 |
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 699,260 | 52,067 | SH | | SOLE | | 699,260 | 0 | 0 |
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 9,333,890 | 172,371 | SH | | SOLE | | 9,333,890 | 0 | 0 |
Intuitive Surgical, Inc. | Common | 46120E602 | 28,786,360 | 112,680 | SH | | SOLE | | 28,786,360 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 3,139,402 | 87,840 | SH | | SOLE | | 3,139,402 | 0 | 0 |
IQVIA Holdings Inc. | Common | 46266C105 | 12,553,340 | 63,117 | SH | | SOLE | | 12,553,340 | 0 | 0 |
Ishares Biothechnology ETF | Common | 464287556 | 3,173,332 | 24,569 | SH | | SOLE | | 3,173,332 | 0 | 0 |
iTeos Therapeutics, Inc. | Common | 46565G104 | 622,453 | 45,735 | SH | | SOLE | | 622,453 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 21,624,501 | 147,779 | SH | | SOLE | | 21,624,501 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 111,875,745 | 721,779 | SH | | SOLE | | 111,875,745 | 0 | 0 |
Karuna Therapeutics, Inc. | Common | 48576A100 | 9,709,021 | 53,452 | SH | | SOLE | | 9,709,021 | 0 | 0 |
Koninklijke Philips N.V. | NY Reg Shares | 500472303 | 2,015,931 | 109,860 | SH | | SOLE | | 2,015,931 | 0 | 0 |
Kura Oncology, Inc. | Common | 50127T109 | 3,464,527 | 283,281 | SH | | SOLE | | 3,464,527 | 0 | 0 |
Laboratory Corporation of America Holdings | Common | 50540R409 | 9,186,436 | 40,042 | SH | | SOLE | | 9,186,436 | 0 | 0 |
Lantheus Holdings, Inc. | Common | 516544103 | 6,563,107 | 79,495 | SH | | SOLE | | 6,563,107 | 0 | 0 |
LivaNova plc | Common | G5509L101 | 2,783,890 | 63,880 | SH | | SOLE | | 2,783,890 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 6,403,953 | 182,293 | SH | | SOLE | | 6,403,953 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | Common | 558868105 | 3,023,647 | 12,481 | SH | | SOLE | | 3,023,647 | 0 | 0 |
Mallinckrodt plc | Shares | G5890A102 | 255,503 | 35,048 | SH | | SOLE | | 255,503 | 0 | 0 |
Marinus Pharmaceuticals, Inc. | Common | 56854Q200 | 3,151,782 | 456,780 | SH | | SOLE | | 3,151,782 | 0 | 0 |
McKesson Corp. | Common | 58155Q103 | 23,661,303 | 66,455 | SH | | SOLE | | 23,661,303 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 3,384,527 | 411,743 | SH | | SOLE | | 3,384,527 | 0 | 0 |
Medpace Holdings, Inc. | Common | 58506Q109 | 1,774,252 | 9,435 | SH | | SOLE | | 1,774,252 | 0 | 0 |
Medtronic plc | Shares | G5960L103 | 27,774,961 | 344,517 | SH | | SOLE | | 27,774,961 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 58,740,260 | 552,122 | SH | | SOLE | | 58,740,260 | 0 | 0 |
Mereo BioPharma Group plc | ADS | 589492107 | 1,096,460 | 1,551,082 | SH | | SOLE | | 1,096,460 | 0 | 0 |
Mersana Therapeutics, Inc. | Common | 59045L106 | 667,394 | 162,383 | SH | | SOLE | | 667,394 | 0 | 0 |
Merus N.V. | Common | N5749R100 | 1,270,060 | 69,025 | SH | | SOLE | | 1,270,060 | 0 | 0 |
Mirati Therapeutics, Inc. | Common | 60468T105 | 2,434,918 | 65,490 | SH | | SOLE | | 2,434,918 | 0 | 0 |
Moderna, Inc. | Common | 60770K107 | 49,486,087 | 322,217 | SH | | SOLE | | 49,486,087 | 0 | 0 |
Molina Healthcare, Inc. | Common | 60855R100 | 16,545,861 | 61,856 | SH | | SOLE | | 16,545,861 | 0 | 0 |
MorphoSys AG | Sponsored ADS | 617760202 | 323,375 | 81,867 | SH | | SOLE | | 323,375 | 0 | 0 |
Natera, Inc. | Common | 632307104 | 2,735,581 | 49,272 | SH | | SOLE | | 2,735,581 | 0 | 0 |
National Health Investors, Inc. | Common | 63633D104 | 517,760 | 10,038 | SH | | SOLE | | 517,760 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 11,428,548 | 112,908 | SH | | SOLE | | 11,428,548 | 0 | 0 |
NexGel, Inc. | Common | 65344E107 | 5,516 | 4,243 | SH | | SOLE | | 5,516 | 0 | 0 |
Nkarta, Inc. | Common | 65487U108 | 102,907 | 28,988 | SH | | SOLE | | 102,907 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 12,532,700 | 136,225 | SH | | SOLE | | 12,532,700 | 0 | 0 |
Novavax, Inc. | Common | 670002401 | 442,134 | 63,800 | SH | | SOLE | | 442,134 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 17,715,942 | 111,323 | SH | | SOLE | | 17,715,942 | 0 | 0 |
Oculis Holding AG | Common | 952KVL905 | 11,047,302 | 1,690,741 | SH | | SOLE | | 11,047,302 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 8,399,329 | 306,433 | SH | | SOLE | | 8,399,329 | 0 | 0 |
Option Care Health, Inc. | Common | 68404L201 | 2,064,256 | 64,975 | SH | | SOLE | | 2,064,256 | 0 | 0 |
Perrigo Company plc | Shares | G97822103 | 1,837,405 | 51,224 | SH | | SOLE | | 1,837,405 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 72,423,101 | 1,775,076 | SH | | SOLE | | 72,423,101 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 13,043,669 | 873,655 | SH | | SOLE | | 13,043,669 | 0 | 0 |
Praxis Precision Medicines, Inc. | Common | 74006W108 | 60,675 | 75,000 | SH | | SOLE | | 60,675 | 0 | 0 |
Precision BioSciences, Inc. | Common | 74019P108 | 169,209 | 224,534 | SH | | SOLE | | 169,209 | 0 | 0 |
Prometheus Biosciences, Inc. | Common | 74349U108 | 5,423,738 | 50,538 | SH | | SOLE | | 5,423,738 | 0 | 0 |
Pyxis Oncology, Inc. | Common | 747324101 | 2,840,295 | 708,303 | SH | | SOLE | | 2,840,295 | 0 | 0 |
R1 RCM Inc. | Common | 77634L105 | 5,352,765 | 356,851 | SH | | SOLE | | 5,352,765 | 0 | 0 |
Rallybio Corporation | Common | 75120L100 | 9,861,553 | 1,727,067 | SH | | SOLE | | 9,861,553 | 0 | 0 |
Reata Pharmaceuticals, Inc. Class A | Class A | 75615P103 | 1,622,922 | 17,850 | SH | | SOLE | | 1,622,922 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 117,542,359 | 143,053 | SH | | SOLE | | 117,542,359 | 0 | 0 |
Repare Therapeutics Inc. | Common | 760273102 | 286,836 | 29,150 | SH | | SOLE | | 286,836 | 0 | 0 |
ResMed Inc. | Common | 761152107 | 16,027,659 | 73,189 | SH | | SOLE | | 16,027,659 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 5,872,590 | 510,660 | SH | | SOLE | | 5,872,590 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 6,718,367 | 123,454 | SH | | SOLE | | 6,718,367 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 39,371,553 | 285,653 | SH | | SOLE | | 39,371,553 | 0 | 0 |
Scholar Rock Holding Corp. | Common | 80706P103 | 870,664 | 108,833 | SH | | SOLE | | 870,664 | 0 | 0 |
Seagen Inc. | Common | 81181C104 | 45,487,518 | 224,663 | SH | | SOLE | | 45,487,518 | 0 | 0 |
Smith & Nephew plc | Sponsored ADR | 83175M205 | 5,071,526 | 181,710 | SH | | SOLE | | 5,071,526 | 0 | 0 |
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 11,254,464 | 147,677 | SH | | SOLE | | 11,254,464 | 0 | 0 |
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 86,003 | 114,670 | SH | | SOLE | | 86,003 | 0 | 0 |
STERIS plc | Shares | G8473T100 | 5,943,452 | 31,072 | SH | | SOLE | | 5,943,452 | 0 | 0 |
Stryker Corp. | Common | 863667101 | 20,433,372 | 71,578 | SH | | SOLE | | 20,433,372 | 0 | 0 |
Sutro Biopharma, Inc. | Common | 869367102 | 454,395 | 98,354 | SH | | SOLE | | 454,395 | 0 | 0 |
Syndax Pharmaceuticals, Inc. | Common | 87164F105 | 2,486,183 | 117,717 | SH | | SOLE | | 2,486,183 | 0 | 0 |
Tactile Systems Technology, Inc. | Common | 87357P100 | 565,373 | 34,432 | SH | | SOLE | | 565,373 | 0 | 0 |
Takeda Pharmaceutical Company Ltd. | Sponsored ADS | 874060205 | 1,731,603 | 105,073 | SH | | SOLE | | 1,731,603 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 4,067,911 | 459,651 | SH | | SOLE | | 4,067,911 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 54,008,751 | 93,705 | SH | | SOLE | | 54,008,751 | 0 | 0 |
Theseus Pharmaceuticals, Inc. | Common | 88369M101 | 666,000 | 75,000 | SH | | SOLE | | 666,000 | 0 | 0 |
Travere Therapeutics, Inc. | Common | 89422G107 | 9,412,515 | 418,520 | SH | | SOLE | | 9,412,515 | 0 | 0 |
TScan Therapeutics, Inc. | Common | 89854M101 | 420,000 | 200,000 | SH | | SOLE | | 420,000 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 2,689,307 | 67,065 | SH | | SOLE | | 2,689,307 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 13,140,262 | 652,446 | SH | | SOLE | | 13,140,262 | 0 | 0 |
United Therapeutics Corp. | Common | 91307C102 | 13,706,352 | 61,200 | SH | | SOLE | | 13,706,352 | 0 | 0 |
Unitedhealth Group Inc. | Common | 91324P102 | 110,667,818 | 234,173 | SH | | SOLE | | 110,667,818 | 0 | 0 |
Universal Health Realty Income Trust | Common | 91359E105 | 541,622 | 11,258 | SH | | SOLE | | 541,622 | 0 | 0 |
Vaxcyte, Inc. | Common | 92243G108 | 187,400 | 5,000 | SH | | SOLE | | 187,400 | 0 | 0 |
VectivBio Holding AG | Common | H9060V101 | 5,872,372 | 682,834 | SH | | SOLE | | 5,872,372 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 2,890,621 | 66,681 | SH | | SOLE | | 2,890,621 | 0 | 0 |
Veradigm, Inc. | Common | 01988P108 | 5,592,969 | 428,580 | SH | | SOLE | | 5,592,969 | 0 | 0 |
Vertex Pharmaceuticals Inc. | Common | 92532F100 | 104,081,169 | 330,343 | SH | | SOLE | | 104,081,169 | 0 | 0 |
VYNE Therapeutics, Inc. | Common | 92941V308 | 23,162 | 7,520 | SH | | SOLE | | 23,162 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 2,973,988 | 41,484 | SH | | SOLE | | 2,973,988 | 0 | 0 |
West Pharmaceutical Services, Inc. | Common | 955306105 | 5,209,523 | 15,036 | SH | | SOLE | | 5,209,523 | 0 | 0 |
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 2,996,124 | 83,714 | SH | | SOLE | | 2,996,124 | 0 | 0 |
Zai Lab Ltd. | ADR | 98887Q104 | 1,152,126 | 34,640 | SH | | SOLE | | 1,152,126 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 8,702,395 | 67,356 | SH | | SOLE | | 8,702,395 | 0 | 0 |
Zoetis Inc. | Class A | 98978V103 | 22,787,966 | 136,914 | SH | | SOLE | | 22,787,966 | 0 | 0 |